Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Micar Innovation (Micar21) logo — Micar Innovation - Drug Discovery Factory for novel drug mol...

Micar Innovation (Micar21)

Micar Innovation - Drug Discovery Factory for novel drug molecules (structure based in silico drug design & AI )

Founded 2016 Bulgaria Bulgaria 3 employees AI, Biotechnology +2

General Information

Company Name Micar Innovation (Micar21)
Founded Year 2016
Location Bulgaria Bulgaria
Employees 3
Industries AI, Biotechnology, Health Care +1
Social

BounceWatch is an independent company data service, not affiliated with Micar Innovation (Micar21). To contact Micar Innovation (Micar21), visit micar21.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Micar Innovation (Micar21) compare?

A PDF of Micar Innovation (Micar21) and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Micar Innovation (Micar21) soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Micar Innovation (Micar21)

Micar Innovation (Micar21) is a pioneering drug discovery factory, utilizing in silico drug design and AI to create novel drug molecules for various diseases such as neuroscience, oncology, cardio-vascularity, dermatology, and rare diseases. The company aims to enhance societal well-being by developing blockbuster drug molecules. Micar21, their drug discovery platform, focuses on small molecule drug candidates for non-clinical Proof-of-Concepts (POCs) and Hit-to-Lead (H2L) achievements in preclinical R&D. The business model centers around licensing intellectual property to commercial partners and establishing spin-out companies. In 2018, Micar Innovation (Micar21) earned recognition as the “Innovative Enterprise of the Year” at the National Innovation Forum, receiving an honorary certificate presented by the President of the Republic of Bulgaria, Mr. Rumen Radev. Additionally, the company was honored with the CIDIC/European Diplomatic, Economic & Academic Centre award for its strategic position in the value chain, delivering impactful no-clinical PoCs and acting as an intellectual property broker for new pharma startups and industry giants. Moreover, Micar Innovation secured the “Best Biotech Startup 2017” award by the 4th CEE Startup Awards. The company's global influence is substantiated by its inclusion in the Roots Analysis' report on the “Computer-Aided Drug Discovery Services Market 2018-2030” alongside renowned corporations like Sanofi and Merck. With its innovative approach and accolades, Micar Innovation (Micar21) showcases potential for transformation and advancement within the Biotechnology, Health Care, and Pharmaceutical industries.

Business keywords: Drug Discovery, Innovation, Pharmaceuticals, AI in Drug Design, Preclinical Research, Neuroscience, Oncology, Cardiovascular Research, Rare Diseases, Intellectual Property, Biotech, Computer-Aided Drug Discovery, Market Analysis

No funding data available for Micar Innovation (Micar21) yet.

Micar Innovation (Micar21) Alternatives & Competitors

View All Alternatives
Micar Innovation (Micar21) vs
Biognosys
Biognosys Switzerland

Transforming life sciences with cutting-edge proteomics technology and solutions

Series G
90 employees
Biotechnology, Health Care
Micar Innovation (Micar21) vs
Recursion
Recursion United States

Decoding Biology to Radically Improve Lives

IPO
770 employees
AI, Biotechnology
Micar Innovation (Micar21) vs
Peptris Technologies
Peptris Technologies India

AI plays tetris with proteins

Pre-Seed
11 employees
AI, Biotechnology
View all alternatives

FAQ About Micar Innovation (Micar21)

Micar Innovation - Drug Discovery Factory for novel drug molecules (structure based in silico drug design & AI )
Micar Innovation (Micar21) was founded in 2016.
Micar Innovation (Micar21) is headquartered in Bulgaria.
Micar Innovation (Micar21) operates in AI, Biotechnology, Health Care and Pharmaceutical. Its work centres on Drug Discovery, Innovation, Pharmaceuticals and AI in Drug Design.
Micar Innovation (Micar21) has approximately 3 employees.
Top alternatives and competitors to Micar Innovation (Micar21) include Biognosys, Recursion, Peptris Technologies, Amyl Therapeutics, iktos. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Micar Innovation (Micar21) and Biognosys are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Micar Innovation (Micar21), https://bouncewatch.com/company/micar-innovation-micar21, updated 2 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes